GeneEdit Therapeutics
GeneEdit Therapeutics develops CRISPR-based gene editing therapies for genetic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $500M
About
GeneEdit Therapeutics develops CRISPR-based gene editing therapies for genetic diseases.
CRISPRGenetics & GenomicsGene Therapy
Funding History
1Total raised:$500M
IPO$500M